October 18, 2021
Company Info
| Industry | Finance/Rental/Leasing |
|---|---|
| Sector | Finance |
| Employees | 5,900 |
| CEO | Mr. Jason A. Kulas |
| Address | Building One 2500 Bee Cave Road, Rollingwood, TX 78746 |
|---|---|
| Phone | 1.512.314.3400 |
| Website | www.ezcorp.com |
EZCORP, Inc. provides pawn loans in the United States and Latin America. It operates its business through following segments: U.S. Pawn, Latin America Pawn, Lana, and Other International. The U.S. Pawn includes its EZPAWN, Value Pawn & Jewelry and other branded pawn operations in United States. The Latin America Pawn consist of Empeno Facil & other branded pawn operations in Mexico and GuatePrenda & MaxiEfectivo pawn operations in Guatemala, El Salvador, Honduras and Peru. The Lana segment is customer-centric web-based engagement platform. The Other International segment involves consumer finance activities in Canada. The company was founded in 1989 and is headquartered in Rollingwood, TX.
Competitors
| Company Name | 3 Month %Change |
1 Year %Change |
|---|---|---|
| EZCORP, Inc. | 33.11% | 54.99% |
| American Finance Trust, Inc. | -0.70% | 31.49% |
| Banc of California, Inc. | 14.97% | 72.05% |
| TPG RE Finance Trust, Inc. | -3.17% | 49.36% |
| Forestar Group Inc. | 0.05% | 5.98% |
Statement Summary
as of 4:00 ET PM 10/15/2021| Total Assets (MRQ) | 1.2 B |
|---|---|
| Total Liabilities (MRQ) | 565.4 M |
| Shareholders’ Equity (MRQ) | 673.2 M |
| Total Revenue (Annual) | 174.0 M |
| Net Income (Annual) | -2.6 M |
Earnings And Estimates
as of 4:00 ET PM 10/15/2021
| Current Qtr EPS Estimate | -0.03 |
|---|---|
| Current FY EPS Estimate | 0.20 |
| Long Term EPS Growth Estimate | 14.00 |
| Next Expected Earnings Date | 12/9/2021 |
EZPW vs S&P 500
as of 10/15/2021| Relative To S&P 500 |
EZPW | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 4:00 ET PM 10/15/2021| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/2021 | -0.03 | -0.03 | +20.00% |
| 03/2021 | 0.08 | 0.17 | +126.67% |
| 12/2020 | -0.05 | 0.13 | -388.89% |
| 09/2020 | -0.09 | 0.07 | -182.35% |
| 06/2020 | 0.07 | -0.01 | -115.00% |
| 03/2020 | 0.17 | 0.17 | +2.00% |
| 12/2019 | 0.22 | 0.16 | -25.58% |
| 09/2019 | 0.19 | 0.19 | -1.30% |
Financial Strength
as of 4:00 ET PM 10/15/2021| Pre-Tax Margin | -0.44 |
|---|---|
| Net Margin | 43.21 |
| Operating Margin | 2.42 |
| Return On Equity | -2.42 |
| Return On Assets | -1.33 |
| Inventory Turnover (TTM) | 2.92 |
| Sales Growth (MRQ) | 0.86 |
Ratios
as of 4:00 PM ET 10/15/2021| Price/Earnings (TTM) | n/a |
|---|---|
| Price/Book (MRQ) | 0.67 |
| Price/Cash Flow (TTM) | 17.31 |
| Book Value (MRQ) | 12.01 |
| Quick Ratio (MRQ) | 3.53 |
| Current Ratio (MRQ) | 4.17 |
| Total Debt/Equity (MRQ) | 0.68 |
Short Interest
as of 10:55 AM ET 10/18/2021| % Short - 0.00% | |
| % Remaining Float - 100.00% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | n/a | n/a |
| Short Interest Shares | 0 | 0 |
| Short Interest Ratio | 0.0 | 0.0 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 4:00 ET PM 10/15/2021| Current Qtr (09/2021) |
Next Qtr (12/2021) |
|
|---|---|---|
| Consensus Estimate | $-0.03 | $0.14 |
| # of Estimates | 3 | 3 |
| High Estimate | $-0.01 | $0.24 |
| Low Estimate | $-0.04 | $0.09 |
| Year Ago EPS | $-0.42 | $0.08 |
| Year Over Year Growth Estimate | -93.71% | 84.71% |
| Current Yr (09/2021) |
Next Yr (09/2022) |
|
|---|---|---|
| Consensus Estimate | $0.20 | $0.62 |
| # of Estimates | 3 | 3 |
| High Estimate | $0.26 | $0.83 |
| Low Estimate | $0.09 | $0.47 |
| Year Ago EPS | $0.39 | $0.20 |
| Year Over Year Growth Estimate | -49.57% | 215.25% |
| Current Qtr (09/2021) |
Next Qtr (12/2021) |
Current Year (09/2021) |
Next Year (09/2022) |
|
|---|---|---|---|---|
| Consensus Estimate | $-0.03 | $0.14 | $0.20 | $0.62 |
| # of Estimates | 3 | 3 | 3 | 3 |
| High Estimate | $-0.01 | $0.24 | $0.26 | $0.83 |
| Low Estimate | $-0.04 | $0.09 | $0.09 | $0.47 |
| Year Ago EPS | $-0.42 | $0.08 | $0.39 | $0.20 |
| Year Over Year Growth Estimate | -93.71% | 84.71% | -49.57% | 215.25% |
Insider Information Summary
as of 09/30/2021| % Insiders - 2.92% | |
| % Remaining Total Shares - 97.08% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | 0.00 | 0.00 |
| Shares Bought | 0.00 | 0.00 |
| Shares Sold | 0.00 | 0.00 |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Learn to Trade Like a Pro
Master The Market with the Help of Our Financial Experts
LATEST NEWS
Latest News
EZCORP Promotes Timothy Jugmans To Chief Financial Officer
May 4, 2021 5:49 PM EDT
EZCORP Reduces Size Of Board Of Directors As Terms Expire
Feb 18, 2021 9:00 AM EST
EZCORP Promotes Jason Kulas To Chief Executive Officer
Jul 6, 2020 8:24 AM EDT
EZCORP Appoints Jason Kulas President And Chief Financial Officer
Feb 24, 2020 4:25 PM EST
Rent-A-Center Adopts 'Poison Pill' Following Activist Campaign
Mar 29, 2017 7:30 AM EDT
Bank fees, payday loans to get less scrutiny from Trump's consumer watchdog
Nov 10, 2016 3:56 PM EST
Trade-Ideas: EZCORP (EZPW) Is Today's Strong On High Relative Volume Stock
Jun 6, 2016 10:05 AM EDT
EZCorp (EZPW) Weak On High Volume
Dec 24, 2015 10:18 AM EST
EZCorp (EZPW) Highlighted As Weak On High Volume
May 21, 2015 10:04 AM EDT
Why EZCORP (EZPW) Stock Is Down in After-Hours Trading Today
Oct 6, 2014 4:55 PM EDT
Why EZCORP (EZPW) Stock Is Down Today
Jul 21, 2014 10:57 AM EDT
Why EZCORP (EZPW) Stock Is Falling Today
Jun 18, 2014 10:42 AM EDT
Why EZCORP (EZPW) Is Up in After-Hours Trading Today
Jun 16, 2014 4:54 PM EDT
Melvin: Looking at Long Shots and Turnarounds
Mar 19, 2014 2:00 PM EDT
Top Insider Trades: JPM TXN EZPW UFI
Feb 4, 2014 9:25 AM EST
4 Stocks Breaking Out on Big Volume
Jan 30, 2014 6:00 AM EST
Why Ezcorp (EZPW) Is Surging Today
Jan 29, 2014 12:18 PM EST
Recent Articles from TheStreet
Netflix Earnings Preview: Can 'Squid Games' Send Stock to Highs?
Netflix stock lately has been on fire, one of the best-performing FAANG components. Here's how to trade it after its Tuesday earnings report.
Facebook Stock Rises on Plan to Hire 10,000 EU Workers
Facebook plans to create 10,000 jobs in the European Union over the next five years.
Biogen Stock Drops as ALS Treatment Fails Phase 3 Study
Biogen is engaging with regulators, the medical community, patient groups and other key stakeholders around the world to determine its potential next steps.
Adamis Pharma Stock Jumps as FDA Clears Opioid-Overdose Treatment
Drug overdoses are the leading cause of death for people under age 50 in the U.S. Adamis just got FDA approval for an opioid-overdose treatment.
Toyota and Stellantis Both Plan U.S. Battery-Factory Investments
Toyota and Stellantis said they’re creating battery factories in the U.S., as the race for electric cars keeps on truckin’.
Apple: Buy or Sell on Monday’s Event? Check the Chart.
Apple's October event may help break the stock out of its current trading range. The question is: Which way will it break?
Netflix 'Squid Game' Valuation Pegged at $900 Million
Netflix values its hit show "Squid Game" at nearly $900 million, 40 times its cost of production, a media report said.
Amazon Execs' Use-of-Data Remarks Subject of Congressional Inquiry
A bipartisan group of five House members is questioning Amazon's claims that it doesn't use third-party-seller data for its own private-label offerings.
Square Mulls Building Bitcoin Mining System, CEO Dorsey Says
Jack Dorsey, CEO of Square, said the payment-tech company is looking at building a bitcoin mining system.
CLOSE
CLOSE
CLOSE
CLOSE